TREM2 agonists

TW202631621APending Publication Date: 2026-08-01F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
F HOFFMANN LA ROCHE & CO AG
Filing Date
2025-10-03
Publication Date
2026-08-01
Patent Text Reader

Abstract

***The invention provides compounds having the general formula (I) wherein A1, A2, X1, X2, R1, R2, R3, R3’, R4, R4’, and R7 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds in the treatment or prevention of diseases that are associated with TREM2. ***
Need to check novelty before this filing date? Find Prior Art